Janux Therapeutics Inc
NASDAQ:JANX 3:59:51 PM EDT
| Market Cap (Intraday) | 1.29B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $29.98 |
| 50-Day MA | $29.94 |
| 200-Day MA | N/A |
Janux Therapeutics Inc Stock, NASDAQ:JANX
11099 North Torrey Pines Park, Suite 290, La Jolla, California 92037
United States of America
Phone: +1.858.750.4700
Number of Employees:
Description
Janux Therapeutics, Inc. operates preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded in June 2017 and is headquartered in La Jolla, CA.